| 產(chǎn)品名稱 | Hesperadin |
| 產(chǎn)品貨號(hào) | Axon 2096 CAS [422513-13-1] MF C29H32N4O3SMW 516.65 Purity: 99% Soluble in DMSO Description A rapid, reversible and ATP-competitive inhibitor of Aurora B References Certificates Categories Extra info S Hauf et al. The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore–microtubule attachment and in maintaining the spindle assembly checkpoint. J. Cell Biol. 2003, 16192), 281.? ? F Sessa et al. Mechanism of Aurora B activation by INCENP and inhibition by hesperadin. Mol. Cell, 2005, 18(3), 379.? Certificate of Analysis Material Safety Data Sheet Cell Cycle Regulation Cell Signaling & Oncology Epigenetics EC 2.7.11.1 Aurora Reversible and ATP-competitive inhibitor of Aurora B Chemical name (Z)-N-(2-oxo-3-(phenyl(4-(piperidin-1-ylmethyl)phenylamino)methylene)indolin-5-yl)ethanesulfonamide Parent CAS No. [422513-13-1] Order Size Unit Price Stock 5 mg €95.00 In Stock |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢價(jià)，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
HesperadinAxon 2096 CAS [422513-13-1] MF C29H32N4O3S
Description
A rapid, reversible and ATP-competitive inhibitor of Aurora B
Reversible and ATP-competitive inhibitor of Aurora B
Chemical name(Z)-N-(2-oxo-3-(phenyl(4-(piperidin-1-ylmethyl)phenylamino)methylene)indolin-5-yl)ethanesulfonamide Parent CAS No.[422513-13-1] |
| 產(chǎn)品資料 |
